ONCOLOGY Vol 33 No 9 | Oncology

Drugs in the Pipeline: Non-Small-Cell Lung Cancer

September 20, 2019

Several promising drugs for the treatment of lung cancer have been garnering attention over recent years. These new treatments have been highlighted at conferences and are sure to impact the standard of care.

Practical Dosing Considerations for Venetoclax

September 20, 2019

With FDA-approved indications for both chronic lymphocytic leukemia and acute myeloid leukemia, and continued investigation within multiple disease states, venetoclax has become an exciting oral targeted therapy among oncologists.